INS and metabolic disease: Results of a meta-analysis study including 763 participants with metabolic diseases from 16 randomized controlled trials revealed that folate supplementation significantly leads to decreases in insulin levels and HOMA-IR, but does not seem to affect FPG and HbA1c levels (47).